Ombitasvir/paritaprevir/ritonavir plus dasabuvir regimen may be used safely in combination with sirolimus for the treatment of chronic hepatitis C. [electronic resource]
Producer: 20181029ISSN:- 1757-790X
- 2-Naphthylamine
- Aged
- Anilides -- therapeutic use
- Antiviral Agents -- therapeutic use
- Carbamates -- therapeutic use
- Cyclopropanes
- Drug Interactions
- Drug Therapy, Combination
- End Stage Liver Disease -- surgery
- Hepatitis C, Chronic -- drug therapy
- Humans
- Lactams, Macrocyclic
- Liver Transplantation
- Macrocyclic Compounds -- therapeutic use
- Male
- Proline -- analogs & derivatives
- Ritonavir -- therapeutic use
- Sirolimus -- therapeutic use
- Sulfonamides -- therapeutic use
- Treatment Outcome
- Uracil -- analogs & derivatives
- Valine
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.